ArticleTobacco induced diseases2026
Global, regional, and 204 countries burden of disease attributed to secondhand smoke-related COPD, 1990-2021: A secondary data analysis of the Global Burden of Disease Study 2021.
Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChronic obstructive pulmonary disease (COPD) imposes a significant economic burden on global public health systems. This secondary data analysis aims to estimate the disease burden of COPD attributable to secondhand smoke exposure from 1990 to 2021.
methodsData on mortality, age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years rate (ASDR) for COPD attributable to secondhand smoke exposure were collected from the Global Burden of Disease (GBD 2021) database. The percentage changes in estimated annual percentage change, number of deaths, and number of disability-adjusted life years were calculated. The associations between ASMR and sociodemographic index (SDI), as well as between ASDR and SDI, were also investigated. The autoregressive integrated moving average time series model was used to project future trends through 2031.
resultsBetween 1990 and 2021, the number of deaths worldwide attributable to secondhand smoke exposure leading to COPD increased. ASMR decreased from 11.36 (95% UI: 4.52-18.55) to 5.87 (95% UI: 2.29-9.72), while ASDR decreased from 234.01 (95% UI: 93.58-380.47) to 120.94 (95% UI: 47.2-197.93). In 2021, China had the highest mortality (117387.96; 95% UI: 47776.16-195915.33), while Papua New Guinea had the highest ASMR (31.63; 95% UI: 11.96-54.96) and ASDR (597.51; 95% UI: 226.75-1036.97). The decline in COPD mortality and ASDR was greater among females than among males. SDI exhibited a nonlinear association with both ASMR and ASDR, with SDI=0.42 representing the inflection point for this relationship. Furthermore, the predictive model estimates that ASMR and ASDR attributable to secondhand smoke exposure for COPD will continue declining through 2031.
conclusionsGlobally, both ASMR and ASDR for COPD attributable to secondhand smoke exposure have shown a declining trend, which is projected to continue. However, the magnitude of decline and absolute disease burden vary across income-heterogeneous countries. There is an urgent need to strengthen awareness interventions targeting vulnerable populations and enforce indoor smoke-free policies to prevent further harm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.